Cryptococcal Meningitis: Limited Access To Essential Anti-cryptococcal Drugs And Ten Steps To Improve The Situation

Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries
Loyse A, Thangaraj H, Easterbrook P, Ford N, Roy M, Chiller T, Govender N, Harrison TS, Bicanic T. Lancet Infect Dis. 2013 May 31.
This is an advocacy piece that was published in Lancet ID this week. It highlights issues around limited access to essential anti-
cryptococcal drugs and proposes ten steps to improve the situation.  The full article can be accessed through the Lancet ID website:

or through the SA HIV Clinicians’ Society

Diseases A-Z Index



Share on facebook
Share on twitter
Share on linkedin